DiscoverUnseen Upside: Investments Beyond Their ReturnsS5:E5 The Maternal Health Crisis: Investing for Change
S5:E5 The Maternal Health Crisis: Investing for Change

S5:E5 The Maternal Health Crisis: Investing for Change

Update: 2024-12-03
Share

Description

There’s a maternal health crisis in the United States, with high rates of maternal mortality, especially among marginalized communities. But what is being done to improve it? 

Through conversations with those on the front lines, we uncover the stark health inequities that exist in maternal healthcare and the developments created to tackle them. We also hear from mothers who have firsthand experience with Preeclampsia—a serious pregnancy complication and one of the many causes of maternal mortality— and one company on a quest to cure it.  

Guests include:



  • Scott Gottlieb, MD, Partner at New Enterprise Associates and Former FDA Commissioner


  • Scott Johnson, MD, Chief Executive Officer and Co-Founder at Comanche Biopharma


  • Jennell Lynch, Chief Executive Officer and Founder at Executive Doula Agency 


  • Theresa Hajer, Head of US Venture Capital Research at Cambridge Associates


Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company.

Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

S5:E5 The Maternal Health Crisis: Investing for Change

S5:E5 The Maternal Health Crisis: Investing for Change

Cambridge Associates